Ars TechnicaRadioactive drugs strike cancer with precision
Tumor-seeking radiopharmaceuticals promise targeted treatments with fewer side effects.
Gregory@arstechnica this is a dead end. Michael Levin's research makes all these tumor-destroying therapies look like stone age technology.